United Therapeutics (NASDAQ:UTHR) Shares Down 3.4% Following Insider Selling

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) fell 3.4% during mid-day trading on Wednesday following insider selling activity. The company traded as low as $236.07 and last traded at $239.32. 136,394 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 400,432 shares. The stock had […]

Related Keywords

United States ,Blackrock ,New Zealand General ,New Zealand ,Wellington ,Martinea Rothblatt ,Paula Mahon , ,Wellington Management Group ,Nasdaq ,Blackrock Inc ,United Therapeutics Corporation ,United Therapeutics Company Profile ,Wells Fargo Company ,Securities Exchange Commission ,Norges Bank ,United Therapeutics Co ,United Therapeutics ,Get Free Report ,Exchange Commission ,Therapeutics Trading Down ,Management Group ,Street Corp ,Avidity Partners Management ,Therapeutics Corporation ,United Therapeutics Daily ,Nasdaq Uthr ,Suthr ,Medical ,91307c10 ,Stocks ,Technicals ,